Skip to main content
. 2013 Jul 27;5(7):364–371. doi: 10.4254/wjh.v5.i7.364

Table 5.

Adverse events attributed to both treatment arms

Adverse events (CTCAE grades 1-3) TACE alone TACE + sorafenib P value
Hand foot skin reaction 0 2 0.554
Diarrhea 0 1
Hypertension (mild) 0 1
Abdominal pain (mild) 6 1
Nausea, vomiting 3 0
Elevated liver enzymes (< 2 times of normal limits) 1 2

TACE: Transarterial chemoembolization; CTCAE: Common terminology criteria for adverse events.